You are here

CELSENSE, INC.

Company Information
Address
603 STANWIX ST STE 348
PITTSBURGH, PA 15222-1425
United States


https://www.celsense.com

Information

UEI: F1W7G1FLD9S5

# of Employees: 3


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Functionalized perfluorocarbon nanoemulsions for enhanced cell labeling for fluorine-19 MRI detection

    Amount: $224,828.00

    This project aims to develop and commercialize a novel MRI probe technology for the cell therapy tools market. This project will transfer technology invented in the academic lab of Dr. Ahrens at UCSD, ...

    STTRPhase I2020Department of Health and Human Services National Institutes of Health
  2. Product for sensitive imaging of cells in vivo

    Amount: $1,543,788.00

    In this Phase 2 application we aim to continue development and commercialization of a novel and sensitive magnetic resonance imaging (MRI) probe for the cell therapy tools market. We propose to implem ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  3. Product for sensitive imaging of cells in vivo

    Amount: $340,802.00

    This project aims to develop and commercialize a novel and highly sensitive MRI probe technology for the cell therapy tools marketThis project will transfer technology invented in the academic lab of ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
  4. Imaging cellular therapy for stress urinary incontinence

    Amount: $169,296.00

    DESCRIPTION (provided by applicant): Urinary incontinence (UI) is one of the most prevalent conditions, affecting approximately 40% of women in the United States and the Western world. Stress urinary ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  5. Platform for myocardial infarct MRI and delivery of therapeutics

    Amount: $379,160.00

    Myocardial infarction (MI) afflicts more than one million persons per year in the United States alone. MI results in permanent left ventricle (LV) scarring that causes diminished pump efficiency and, ...

    STTRPhase I2012Department of Health and Human Services National Institutes of Health
  6. Dual Mode Nanoemulsions for 19F MRI and Fluorescence Detection

    Amount: $132,282.00

    DESCRIPTION (provided by applicant): Recently, scientists at Carnegie Mellon University (CMU) have invented a compelling technology that makes transplanted cells visible with magnetic resonance imagi ...

    STTRPhase I2009Department of Health and Human Services National Institutes of Health
  7. Analysis of Cell Sense Labeled Human Cells

    Amount: $273,009.00

    DESCRIPTION (provided by applicant): Cellular therapeutics represent great potential for curing and alleviating symptoms associated with debilitating human diseases, such as cancer, cardiovascular dis ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government